Skip to main content

DCVC Opportunity Fund II GP, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1668343 PALO ALTO, CA

Position in RXRX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,130,002
-$4,030,164 QoQ
Shares Held
3,951,141
0.0% QoQ
Ownership
0.746%
of shares outstanding
% of Portfolio
87.48%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DCVC Opportunity Fund II GP, LLC holds $12,130,002 across 1 Biotechnology name. RXRX ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RXRX
Recursion Pharmaceuticals, Inc.
This page
3,951,141 $12,130,002

All Filings in RXRX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,130,002 3,951,141
2025-12-31 $16,160,166 3,951,141
2025-09-30 $19,281,568 3,951,141
2025-06-30 $19,992,773 3,951,141
2025-03-31 $20,901,535 3,951,141
2024-12-31 $26,709,713 3,951,141
2024-09-30 $26,038,019 3,951,141
2024-06-30 $29,633,557 3,951,141
2024-03-31 $39,392,875 3,951,141
2023-12-31 $38,958,250 3,951,141
2022-09-30 $42,040,140 3,951,141
2022-06-30 $32,162,287 3,951,141
2022-03-31 $28,290,169 3,951,141
2021-12-31 $67,683,045 3,951,141